The field of HIV toxicology is continuously evolving. Future research is focused on developing novel antiretroviral drugs with fewer side effects, understanding the long-term toxicological impacts of existing drugs, and identifying genetic factors that may influence individual responses to treatment. Advances in personalized medicine and gene editing technologies such as CRISPR hold promise for more tailored and potentially curative approaches to HIV treatment.
